List view / Grid view
23 June 2014 | By Johnson & Johnson
Johnson & Johnson announced that its Board of Directors has appointed D. Scott Davis, Chief Executive Officer and Chairman of United Parcel Service, Inc. as a Director of Johnson & Johnson...
23 June 2014 | By Pfizer
Adults 65 or older can now be immunized with the same Pneumococcal Conjugate Vaccine used in children...
23 June 2014 | By Merck
Merck is commencing, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc...
23 June 2014 | By AbbVie
The board of directors of AbbVie Inc. declared a quarterly cash dividend of $0.42 per share...
23 June 2014 | By Novo Nordisk
New data from the phase 3a SCALE™ Diabetes trial were presented at the International Congress of Endocrinology and the Endocrine Society’s meeting, investigating the effect of liraglutide 3 mg in adults...
23 June 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announces a new study of Pradaxa® (dabigatran etexilate) in patients with atrial fibrillation...
19 June 2014 | By Sanofi
Sanofi announced that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) consistently showed significantly fewer low blood sugar events (hypoglycemia)...
19 June 2014 | By Pfizer
Pfizer Inc. and Cellectis announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets...
19 June 2014 | By Johnson & Johnson
Janssen Pharmaceuticals, Inc. announced that it has entered into an exclusive license agreement with Vertex Pharmaceuticals...
19 June 2014 | By H. Lundbeck A/S
Lundbeck will present results about sexual functioning from a head-to-head study of Brintellix® (vortioxetine) vs. escitalopram in patients with well treated Major Depressive Disorder...
18 June 2014 | By Teva
Teva Pharmaceutical Industries Ltd. announced that it has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7,132,570 for Teva’s wakefulness product, NUVIGIL® (armodafinil) tablet...
18 June 2014 | By Novartis
For its first "Meet Novartis Management" investor day, Novartis gathered more than 20 of its top executives, drawn from the leadership of Pharmaceuticals...
18 June 2014 | By Bristol-Myers Squibb
The Board of Directors of Bristol-Myers Squibb Company declared a quarterly dividend of thirty-six cents per share on the $.10 par value Common Stock of the corporation...
17 June 2014 | By GEA Group
GEA Process Engineering’s Pharmaceutical GMP Spray Drying facility in Copenhagen, Denmark has been granted authorization by the Danish Health and Medicines Authority for spray drying of human medicinal products for commercial use...
17 June 2014 | By kdm communications
Tecan has introduced a Dual Z arm for the popular Cavro® Omni Robot...
